Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis
2025 · New England Journal of Medicine · 60 citations
https://doi.org/10.1056/nejmoa2400327
E
Elisabeth Baudin
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
1.3K
Citations
16
h-index
24
i10-index
Elisabeth Baudin is an academic researcher from Inserm. The author has contributed to research in topics: Malaria Research and Control & Child Nutrition and Water Access & Mosquito-borne diseases and control. The author has an h-index of 16, co-authored 51 publications.
ORCID: 0000-0002-6575-6971Papers by this author
worksThe duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data
2020 · BMC Medicine · 53 citations
https://doi.org/10.1186/s12916-020-1494-3
Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger
2016 · BMC Medicine · 25 citations
https://doi.org/10.1186/s12916-016-0716-1
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data
2022 · BMC Medicine · 14 citations
https://doi.org/10.1186/s12916-022-02265-9
Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial
2025 · The Lancet Respiratory Medicine · 12 citations
https://doi.org/10.1016/s2213-2600(25)00194-8
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
2023 · Trials · 11 citations
https://doi.org/10.1186/s13063-023-07701-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat